How Cannabis Works: Cannabinoids, Terpenes, and Your Body

Understanding how cannabis works in the human body requires moving past marketing labels like 'Indica' or 'Sativa' and looking at the raw pharmacology. The cannabis plant functions as a biochemical delivery system, and your unique response depends on how its molecules interact with your Endocannabinoid System (ECS).

By Harrison4 min read

The ECS: Your Internal Governor

The ECS is the biological infrastructure responsible for keeping your body in a state of homeostasis. It is a signaling network comprised of three main parts:

Endocannabinoids: Your body’s natural messengers, like Anandamide (AEA) and 2-AG, which act as retrograde neurotransmitters.
Cannabinoid Receptors: The biological docking stations (GPCRs) scattered throughout your tissues.
Metabolic Enzymes: Specialized proteins like FAAH and MAGL that act as cleanup crews, breaking down messengers once they have served their purpose.

When you consume phytocannabinoids from cannabis, they may mimic your natural messengers, plugging into this pre-existing system to nudge biological processes in one direction or another.

Receptor Mapping: Why THC and CBD Do Different Things

Where a cannabinoid binds dictates the effect you feel.

CB1: The Central Nervous System Control Center

CB1 receptors are highly concentrated in the brain—specifically the cortex (executive function), hippocampus (memory), and cerebellum (motor control). THC acts as a partial agonist here. It impersonates Anandamide but is harder for your body to break down, which is why the effects may persist longer than a natural neurotransmitter signal.

CB2: The Immune and Inflammatory Regulator

Found mostly in your peripheral tissues, spleen, and white blood cells, CB2 receptors do not mediate psychoactivity. Instead, they act as a "dimmer switch" for inflammation and cytokine production.

Beyond the High: Allosteric Modulation and Terpenes

The nuance in cannabis science lies in how molecules talk to each other.

The CBD-THC Interaction

CBD does not fight THC for the same parking spot. Instead, it acts as a negative allosteric modulator. It binds to a different side of the CB1 receptor, physically shifting the receptor’s shape. This makes it harder for THC to lock in, which is why a high-CBD ratio may blunt the anxiety or racing heart associated with pure THC.

Terpenes: The Pharmacological Catalysts

Terpenes are bioactive compounds that dictate the kinetics of your experience:

Myrcene: Increases blood-brain barrier permeability, acting as a fast-pass for cannabinoids into the CNS.
Beta-Caryophyllene: Functions as a selective CB2 agonist. It is technically a cannabinoid itself and supports the management of physical inflammation.
Alpha-Pinene: Inhibits the breakdown of acetylcholine, helping to sharpen memory and potentially counteracting the cognitive clouding often associated with THC.
Linalool: Interacts with the GABA system, which may support sedation and muscle relaxation.

ECS Tone and Genetic Variance

Your "ECS Tone"—your baseline receptor density and enzyme levels—is as unique as your fingerprint.

The FAAH Factor: Some individuals possess a genetic mutation resulting in lower FAAH enzyme production. This means they naturally produce higher levels of Anandamide. These people might find they need significantly less cannabis to feel an effect, or they might be more prone to anxiety if they overwhelm their system.

Clinical Endocannabinoid Deficiency (CECD): Research points toward the idea that some chronic issues, such as fibromyalgia or migraines, may be a result of a "leaky" or underactive ECS. In these cases, cannabis might be used as a supplement to address a physiological shortfall.

The Biphasic Rule: Why "More" Isn't Always "Better"

Cannabinoids exhibit a biphasic dose-response curve. This means a low dose and a high dose of the exact same molecule can produce opposite results. For instance, a small dose of THC (2.5mg–5mg) is often anxiolytic, but pushing that dose too high (20mg+) can hyper-stimulate the amygdala and trigger the very anxiety you were trying to address.

If you are looking for a specific result—whether it is physical analgesia or cognitive clarity—do not look at the strain name. Look at the Certificate of Analysis (COA). Focus on the ratios of cannabinoids to specific terpenes; that data provides an objective map for how a product may interact with your biology.

Legal Disclaimer: This content is for educational and informational purposes only and does not constitute medical advice. Always seek the advice of a physician regarding a medical condition. Efficacy has not been confirmed by FDA-approved research. Check your local laws regarding cannabis and terpene use.

Sources

Devane WA, Hanus L, Breuer A, et al. (1992). Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science. 258(5090):1946-49. PubMed

Pertwee RG. (2008). The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin. Br J Pharmacol. 153(2):199-215. PubMed

Russo EB. (2011). Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol. 163(7):1344-64. PubMed

Mechoulam R, Parker LA. (2013). The endocannabinoid system and the brain. Annu Rev Psychol. 64:21-47. PubMed

Gertsch J, Leonti M, Raduner S, et al. (2008). Beta-caryophyllene is a dietary cannabinoid. Proc Natl Acad Sci USA. 105(26):9099-104. PubMed